All of those international conferences also came good. It meant that we had a huge network of trusted colleagues all over the world. When we wanted to set up trials in Brazil or South Africa, Andy wasn’t just pitching up unannounced at a hospital in Rio or Johannesburg. We had existing relationships, we knew all the people already, and we knew they would be able to conduct high-quality clinical trials because they already had the infrastructure and experience.
